Search

everythinglearnresearchcommunity

for

Search:↓

Low levels of ferritin, TSH, and certain vitamins are linked to hair loss in women of different ages.

Low Vitamin D levels are linked to female hair loss.

Severe COVID-19 may increase lung cancer risk and affect treatment in women due to hormonal changes.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

CBD may help restore hair growth-related protein levels in alopecia caused by hormones or other factors.

3βHSD2 is not useful for diagnosing PCOS.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

Depressed individuals have higher hair sodium and potassium levels, similar to changes seen in astronauts.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.

Hair can show daily calcium changes, linked to body calcium levels and influenced by hormones, and can help assess calcium metabolism issues.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

Treating hyperprolactinemia can help manage PCOS symptoms.

Losing weight, possibly through bariatric surgery, is key to improving PCOS and hyperandrogenism symptoms in obese patients.